tradingkey.logo
搜尋

Co-Diagnostics Inc

CODX
添加自選
1.440USD
-0.120-7.69%
收盤 07-31 16:00美東報價延遲15分鐘
5.19M總市值
虧損本益比TTM

關於 Co-Diagnostics Inc 公司

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Co-Diagnostics Inc簡介

公司代碼CODX
公司名稱Co-Diagnostics Inc
上市日期Jul 12, 2017
CEOEgan (Dwight H)
員工數量132
證券類型Ordinary Share
年結日Jul 12
公司地址2401 S. Foothill Dr. Suite D
城市SALT LAKE CITY
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編84109
電話18014381036
網址https://codiagnostics.com/
公司代碼CODX
上市日期Jul 12, 2017
CEOEgan (Dwight H)

Co-Diagnostics Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Richard Abbott
Mr. Richard Abbott
President
President
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--

常見問題

Co-Diagnostics Inc的前五大股東是誰?

Co-Diagnostics Inc的前五大股東如下:Mr. Richard S. Serbin

有多少機構持有Co-Diagnostics Inc(CODX)的股份?

截至2026Q1,共有75家機構持有Co-Diagnostics Inc的股份,合計持有的股份價值約為248.15K,占公司總股份的6.89% 。與2025Q4相比,機構持股有所增加,增幅為-158736.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有